115 related articles for article (PubMed ID: 1438934)
1. Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited.
Bentzen SM; Thames HD
Radiother Oncol; 1992 Oct; 25(2):143-4. PubMed ID: 1438934
[No Abstract] [Full Text] [Related]
2. No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours.
Dubben HH
Radiother Oncol; 1992 Oct; 25(2):142-3. PubMed ID: 1438933
[No Abstract] [Full Text] [Related]
3. Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck.
Yaes RJ
Radiother Oncol; 1995 Jan; 34(1):81-3. PubMed ID: 7792405
[No Abstract] [Full Text] [Related]
4. Radiotherapy employing three fractions in each day over a continuous period of 12 days.
Saunders MI; Dische S
Br J Radiol; 1986 May; 59(701):523-5. PubMed ID: 3708258
[No Abstract] [Full Text] [Related]
5. Postoperative irradiation for squamous cell carcinomas of the head and neck: analysis of time-dose factors related to control above the clavicles.
Marcus RB; Million RR; Cassissi NJ
Int J Radiat Oncol Biol Phys; 1979; 5(11-12):1943-9. PubMed ID: 544572
[No Abstract] [Full Text] [Related]
6. Twice-daily radiation therapy for head and neck carcinomas.
Wang CC
Front Radiat Ther Oncol; 1988; 22():93-8. PubMed ID: 3350355
[No Abstract] [Full Text] [Related]
7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic neck nodes.
Perez CA; Lee FA; Ackerman LV; Korba A; Purdy J; Powers WE
Int J Radiat Oncol Biol Phys; 1976; 1(9-10):817-27. PubMed ID: 824256
[No Abstract] [Full Text] [Related]
9. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
[No Abstract] [Full Text] [Related]
10. Elective neck irradiation for squamous cell carcinoma of the head and neck: analysis of time-dose factors and causes of failure.
Mendenhall WM; Million RR
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):741-6. PubMed ID: 3710858
[TBL] [Abstract][Full Text] [Related]
11. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
12. Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation.
Medini E; Rao Y; Kim T; Jones TK; Levitt SH
Radiology; 1980 Feb; 134(2):531-2. PubMed ID: 7352244
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of periodical fraction with massive dose for secondary squamous cell carcinomas of the neck].
Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1970 Jan; 29(10):1253-65. PubMed ID: 5266099
[No Abstract] [Full Text] [Related]
14. Carcinoma of the nasopharynx. Review of 146 patients with emphasis on radiation dose and time factors.
Moench HC; Phillips TL
Am J Surg; 1972 Oct; 124(4):515-8. PubMed ID: 4627679
[No Abstract] [Full Text] [Related]
15. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
[TBL] [Abstract][Full Text] [Related]
17. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
Russo G; Haddad R; Posner M; Machtay M
Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
[TBL] [Abstract][Full Text] [Related]
18. Analysis of time-dose factors in clinically positive neck nodes treated with irradiation alone in squamous cell carcinoma of the head and neck.
Mendenhall WM; Million RR; Bova FJ
Int J Radiat Oncol Biol Phys; 1984 May; 10(5):639-43. PubMed ID: 6735752
[TBL] [Abstract][Full Text] [Related]
19. The rationale for neutron irradiation in cancer of the head and neck: a preliminary report.
Ornitz RD; Hussey DH; Parker RG; Rogers CC
Otolaryngol Clin North Am; 1979 Feb; 12(1):219-26. PubMed ID: 440743
[No Abstract] [Full Text] [Related]
20. Continuous, hyperfractionated, accelerated radiotherapy (CHART).
Dische S
Eur J Cancer; 1990; 26(9):927-8. PubMed ID: 2149016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
